At US$8.48, Is Cross Country Healthcare Inc (NASDAQ:CCRN) A Buy?

Cross Country Healthcare Inc (NASDAQ:CCRN), a healthcare company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGS, rising to the highs of $12.86 and falling to the lows of $8.11. This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether Cross Country Healthcare’s current trading price of $8.48 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Cross Country Healthcare’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for Cross Country Healthcare

What is Cross Country Healthcare worth?

Great news for investors – Cross Country Healthcare is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is $16.87, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. What’s more interesting is that, Cross Country Healthcare’s share price is quite stable, which could mean two things: firstly, it may take the share price a while to move to its intrinsic value, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.

What kind of growth will Cross Country Healthcare generate?

NasdaqGS:CCRN Future Profit August 6th 18
NasdaqGS:CCRN Future Profit August 6th 18
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with an extremely negative double-digit change in profit expected over the next couple of years, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Cross Country Healthcare, at least in the near future.

What this means for you:

Are you a shareholder? Although CCRN is currently undervalued, the adverse prospect of negative growth brings about some degree of risk. I recommend you think about whether you want to increase your portfolio exposure to CCRN, or whether diversifying into another stock may be a better move for your total risk and return.

Are you a potential investor? If you’ve been keeping an eye on CCRN for a while, but hesitant on making the leap, I recommend you dig deeper into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Cross Country Healthcare. You can find everything you need to know about Cross Country Healthcare in the latest infographic research report. If you are no longer interested in Cross Country Healthcare, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.